Search of DI notices by substantial shareholder / director - Current Securities   Person being searched Name of substantial shareholder / director: Morgan Stanley Date (dd/mm/yyyy): 28/03/2023 - 28/03/2024   Please click the links under the column "Date of relevant event" to view the details of the DI notices *Notes: (L) - Long Position, (S) - Short Position, (P) - Lending Pool Form Serial Number Date of relevant event (dd/mm/yyyy) Name of listed corporation No. of shares bought/ sold/ involved Reason for disclosure Average price per share No. of shares held after the relevant event (See *Notes above) % of issued voting shares Interests in shares of associated corporation Interests in debentures CS20230922E00130 19/09/2023 Innovent Biologics, Inc. 67,540,613(L) 1704(L)   17,071,032(L) 21,572,153(S) 0(P) 1.06(L) 1.33(S) 0.00(P)     CS20230921E00186 18/09/2023 Innovent Biologics, Inc. 1,300,000(L) 1312(L)   84,774,252(L) 22,414,035(S) 0(P) 5.50(L) 1.45(S) 0.00(P)     CS20230920E00114 15/09/2023 Innovent Biologics, Inc. 750,000(L) 1312(L)   88,947,139(L) 25,491,024(S) 0(P) 5.77(L) 1.65(S) 0.00(P)     CS20230919E00137 14/09/2023 Innovent Biologics, Inc. 3,539,500(L) 1306(L)   91,862,637(L) 27,405,801(S) 0(P) 5.96(L) 1.77(S) 0.00(P)     CS20230918E00132 13/09/2023 Innovent Biologics, Inc. 4,271,500(L) 1305(L)   97,788,475(L) 32,587,559(S) 0(P) 6.34(L) 2.11(S) 0.00(P)     CS20230918E00131 13/09/2023 Innovent Biologics, Inc. 5,925,838(L) 5,181,758(S) 1213(L) 1502(S)   91,862,637(L) 27,405,801(S) 0(P) 5.96(L) 1.77(S) 0.00(P)     CS20230915E00225 12/09/2023 Innovent Biologics, Inc. 68,124,876(L) 1013(L)   97,788,475(L) 32,587,559(S) 0(P) 6.34(L) 2.11(S) 0.00(P)     Page <1>     Displayed: 1 - 7 Total records: 7   TOP